Global Opioid-Induced Constipation Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Date : Jan 2019

Formats :
Report Code : PMR103887907

Category : Pharmaceutical and Healthcare
No Of Pages : 138

Global Opioid-Induced Constipation Market Overview:

Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation. Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation.


This report focuses on the Opioid-Induced Constipation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The opioid analgesics produce analgesia by the activation of the mu receptors found in the CNS and PNS. These drugs affect the motility, tone, and contractility of the bowel functions, which results in the delay in the transit of fecal contents. The opioids also cause a reduction in the secretion of digestive enzymes and also cause partial gastroparesis. Some of the common symptoms of opioid-induced constipation are hard and dry stools, painful defecation, bloating, distention and bulged abdomen, feeling lethargic, and loss of appetite.
The worldwide market for Opioid-Induced Constipation is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new Planet Market Reports study.

Market Segment by Manufacturers, this report covers


AstraZeneca
Takeda Pharmaceutical
Valeant Pharmaceuticals International
Abbott
Bayer
Boehringer Ingelheim
C.B. Fleet
Cosmo Pharmaceuticals
Daewoong
Daiichi Sankyo
GlaxoSmithKline
Ironwood Pharmaceuticals
Johnson & Johnson
Merck
Mundipharma
Nektar Therapeutics
Pfizer
Progenics Pharmaceuticals
Shionogi
SLA Pharma
Sucampo
Synergy Pharmaceuticals
Theravance

Market Segment by Regions, regional analysis covers


North America United States, Canada and Mexico
Europe Germany, France, UK, Russia and Italy
Asia-Pacific China, Japan, Korea, India and Southeast Asia
South America Brazil, Argentina, Colombia etc.
Middle East and Africa Saudi Arabia, UAE, Egypt, Nigeria and South Africa

Market Segment by Type, covers


Solid
Liquid

Market Segment by Applications, can be divided into


Drugstore
Hospital
Others

There are 15 Chapters to deeply display the global Opioid-Induced Constipation market.
Chapter 1, to describe Opioid-Induced Constipation Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Opioid-Induced Constipation, with sales, revenue, and price of Opioid-Induced Constipation, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Opioid-Induced Constipation, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Opioid-Induced Constipation market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Opioid-Induced Constipation sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents

1 Market Overview
1.1 Opioid-Induced Constipation Introduction
1.2 Market Analysis by Type
1.2.1 Solid
1.2.2 Liquid
1.3 Market Analysis by Applications
1.3.1 Drugstore
1.3.2 Hospital
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America United States, Canada and Mexico
1.4.1.1 United States Market States and Outlook 2013-2023
1.4.1.2 Canada Market States and Outlook 2013-2023
1.4.1.3 Mexico Market States and Outlook 2013-2023
1.4.2 Europe Germany, France, UK, Russia and Italy
1.4.2.1 Germany Market States and Outlook 2013-2023
1.4.2.2 France Market States and Outlook 2013-2023
1.4.2.3 UK Market States and Outlook 2013-2023
1.4.2.4 Russia Market States and Outlook 2013-2023
1.4.2.5 Italy Market States and Outlook 2013-2023
1.4.3 Asia-Pacific China, Japan, Korea, India and Southeast Asia
1.4.3.1 China Market States and Outlook 2013-2023
1.4.3.2 Japan Market States and Outlook 2013-2023
1.4.3.3 Korea Market States and Outlook 2013-2023
1.4.3.4 India Market States and Outlook 2013-2023
1.4.3.5 Southeast Asia Market States and Outlook 2013-2023
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook 2013-2023
1.4.4.2 Egypt Market States and Outlook 2013-2023
1.4.4.3 Saudi Arabia Market States and Outlook 2013-2023
1.4.4.4 South Africa Market States and Outlook 2013-2023
1.4.4.5 Nigeria Market States and Outlook 2013-2023
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Opioid-Induced Constipation Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.2 Takeda Pharmaceutical
2.2.1 Business Overview
2.2.2 Opioid-Induced Constipation Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Takeda Pharmaceutical Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.3 Valeant Pharmaceuticals International
2.3.1 Business Overview
2.3.2 Opioid-Induced Constipation Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Valeant Pharmaceuticals International Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.4 Abbott
2.4.1 Business Overview
2.4.2 Opioid-Induced Constipation Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.5 Bayer
2.5.1 Business Overview
2.5.2 Opioid-Induced Constipation Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bayer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.2 Opioid-Induced Constipation Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boehringer Ingelheim Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.7 C.B. Fleet
2.7.1 Business Overview
2.7.2 Opioid-Induced Constipation Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 C.B. Fleet Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.8 Cosmo Pharmaceuticals
2.8.1 Business Overview
2.8.2 Opioid-Induced Constipation Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cosmo Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.9 Daewoong
2.9.1 Business Overview
2.9.2 Opioid-Induced Constipation Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Daewoong Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.10 Daiichi Sankyo
2.10.1 Business Overview
2.10.2 Opioid-Induced Constipation Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Daiichi Sankyo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.11 GlaxoSmithKline
2.11.1 Business Overview
2.11.2 Opioid-Induced Constipation Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GlaxoSmithKline Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.12 Ironwood Pharmaceuticals
2.12.1 Business Overview
2.12.2 Opioid-Induced Constipation Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Ironwood Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.13 Johnson & Johnson
2.13.1 Business Overview
2.13.2 Opioid-Induced Constipation Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Johnson & Johnson Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.14 Merck
2.14.1 Business Overview
2.14.2 Opioid-Induced Constipation Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Merck Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.15 Mundipharma
2.15.1 Business Overview
2.15.2 Opioid-Induced Constipation Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Mundipharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.16 Nektar Therapeutics
2.16.1 Business Overview
2.16.2 Opioid-Induced Constipation Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Nektar Therapeutics Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.17 Pfizer
2.17.1 Business Overview
2.17.2 Opioid-Induced Constipation Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Pfizer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.18 Progenics Pharmaceuticals
2.18.1 Business Overview
2.18.2 Opioid-Induced Constipation Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.19 Shionogi
2.19.1 Business Overview
2.19.2 Opioid-Induced Constipation Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Shionogi Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.20 SLA Pharma
2.20.1 Business Overview
2.20.2 Opioid-Induced Constipation Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 SLA Pharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.21 Sucampo
2.21.1 Business Overview
2.2.2 Opioid-Induced Constipation Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Sucampo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.22 Synergy Pharmaceuticals
2.22.1 Business Overview
2.22.2 Opioid-Induced Constipation Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Synergy Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
2.23 Theravance
2.23.1 Business Overview
2.23.2 Opioid-Induced Constipation Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Theravance Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share 2016-2017
3 Global Opioid-Induced Constipation Sales, Revenue, Market Share and Competition by Manufacturer 2016-2017
3.1 Global Opioid-Induced Constipation Sales and Market Share by Manufacturer 2016-2017
3.2 Global Opioid-Induced Constipation Revenue and Market Share by Manufacturer 2016-2017
3.3 Market Concentration Rate
3.3.1 Top 3 Opioid-Induced Constipation Manufacturer Market Share in 2017
3.3.2 Top 6 Opioid-Induced Constipation Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Opioid-Induced Constipation Market Analysis by Regions
4.1 Global Opioid-Induced Constipation Sales, Revenue and Market Share by Regions
4.1.1 Global Opioid-Induced Constipation Sales and Market Share by Regions 2013-2018
4.1.2 Global Opioid-Induced Constipation Revenue and Market Share by Regions 2013-2018
4.2 North America Opioid-Induced Constipation Sales and Growth Rate 2013-2018
4.3 Europe Opioid-Induced Constipation Sales and Growth Rate 2013-2018
4.4 Asia-Pacific Opioid-Induced Constipation Sales and Growth Rate 2013-2018
4.5 South America Opioid-Induced Constipation Sales and Growth Rate 2013-2018
4.6 Middle East and Africa Opioid-Induced Constipation Sales and Growth Rate 2013-2018
5 North America Opioid-Induced Constipation by Countries
5.1 North America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
5.1.1 North America Opioid-Induced Constipation Sales and Market Share by Countries 2013-2018
5.1.2 North America Opioid-Induced Constipation Revenue and Market Share by Countries 2013-2018
5.2 United States Opioid-Induced Constipation Sales and Growth Rate 2013-2018
5.3 Canada Opioid-Induced Constipation Sales and Growth Rate 2013-2018
5.4 Mexico Opioid-Induced Constipation Sales and Growth Rate 2013-2018
6 Europe Opioid-Induced Constipation by Countries
6.1 Europe Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
6.1.1 Europe Opioid-Induced Constipation Sales and Market Share by Countries 2013-2018
6.1.2 Europe Opioid-Induced Constipation Revenue and Market Share by Countries 2013-2018
6.2 Germany Opioid-Induced Constipation Sales and Growth Rate 2013-2018
6.3 UK Opioid-Induced Constipation Sales and Growth Rate 2013-2018
6.4 France Opioid-Induced Constipation Sales and Growth Rate 2013-2018
6.5 Russia Opioid-Induced Constipation Sales and Growth Rate 2013-2018
6.6 Italy Opioid-Induced Constipation Sales and Growth Rate 2013-2018
7 Asia-Pacific Opioid-Induced Constipation by Countries
7.1 Asia-Pacific Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Opioid-Induced Constipation Sales and Market Share by Countries 2013-2018
7.1.2 Asia-Pacific Opioid-Induced Constipation Revenue and Market Share by Countries 2013-2018
7.2 China Opioid-Induced Constipation Sales and Growth Rate 2013-2018
7.3 Japan Opioid-Induced Constipation Sales and Growth Rate 2013-2018
7.4 Korea Opioid-Induced Constipation Sales and Growth Rate 2013-2018
7.5 India Opioid-Induced Constipation Sales and Growth Rate 2013-2018
7.6 Southeast Asia Opioid-Induced Constipation Sales and Growth Rate 2013-2018
8 South America Opioid-Induced Constipation by Countries
8.1 South America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
8.1.1 South America Opioid-Induced Constipation Sales and Market Share by Countries 2013-2018
8.1.2 South America Opioid-Induced Constipation Revenue and Market Share by Countries 2013-2018
8.2 Brazil Opioid-Induced Constipation Sales and Growth Rate 2013-2018
8.3 Argentina Opioid-Induced Constipation Sales and Growth Rate 2013-2018
8.4 Colombia Opioid-Induced Constipation Sales and Growth Rate 2013-2018
9 Middle East and Africa Opioid-Induced Constipation by Countries
9.1 Middle East and Africa Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Opioid-Induced Constipation Sales and Market Share by Countries 2013-2018
9.1.2 Middle East and Africa Opioid-Induced Constipation Revenue and Market Share by Countries 2013-2018
9.2 Saudi Arabia Opioid-Induced Constipation Sales and Growth Rate 2013-2018
9.3 UAE Opioid-Induced Constipation Sales and Growth Rate 2013-2018
9.4 Egypt Opioid-Induced Constipation Sales and Growth Rate 2013-2018
9.5 Nigeria Opioid-Induced Constipation Sales and Growth Rate 2013-2018
9.6 South Africa Opioid-Induced Constipation Sales and Growth Rate 2013-2018
10 Global Opioid-Induced Constipation Market Segment by Type
10.1 Global Opioid-Induced Constipation Sales, Revenue and Market Share by Type 2013-2018
10.1.1 Global Opioid-Induced Constipation Sales and Market Share by Type 2013-2018
10.1.2 Global Opioid-Induced Constipation Revenue and Market Share by Type 2013-2018
10.2 Solid Sales Growth and Price
10.2.1 Global Solid Sales Growth 2013-2018
10.2.2 Global Solid Price 2013-2018
10.3 Liquid Sales Growth and Price
10.3.1 Global Liquid Sales Growth 2013-2018
10.3.2 Global Liquid Price 2013-2018
11 Global Opioid-Induced Constipation Market Segment by Application
11.1 Global Opioid-Induced Constipation Sales Market Share by Application 2013-2018
11.2 Drugstore Sales Growth 2013-2018
11.3 Hospital Sales Growth 2013-2018
11.4 Others Sales Growth 2013-2018
12 Opioid-Induced Constipation Market Forecast 2018-2023
12.1 Global Opioid-Induced Constipation Sales, Revenue and Growth Rate 2018-2023
12.2 Opioid-Induced Constipation Market Forecast by Regions 2018-2023
12.2.1 North America Opioid-Induced Constipation Market Forecast 2018-2023
12.2.2 Europe Opioid-Induced Constipation Market Forecast 2018-2023
12.2.3 Asia-Pacific Opioid-Induced Constipation Market Forecast 2018-2023
12.2.4 South America Opioid-Induced Constipation Market Forecast 2018-2023
12.2.5 Middle East and Africa Opioid-Induced Constipation Market Forecast 2018-2023
12.3 Opioid-Induced Constipation Market Forecast by Type 2018-2023
12.3.1 Global Opioid-Induced Constipation Sales Forecast by Type 2018-2023
12.3.2 Global Opioid-Induced Constipation Market Share Forecast by Type 2018-2023
12.4 Opioid-Induced Constipation Market Forecast by Application 2018-2023
12.4.1 Global Opioid-Induced Constipation Sales Forecast by Application 2018-2023
12.4.2 Global Opioid-Induced Constipation Market Share Forecast by Application 2018-2023
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures

Figure Opioid-Induced Constipation Picture
Table Product Specifications of Opioid-Induced Constipation
Figure Global Sales Market Share of Opioid-Induced Constipation by Types in 2017
Table Opioid-Induced Constipation Types for Major Manufacturers
Figure Solid Picture
Figure Liquid Picture
Figure Opioid-Induced Constipation Sales Market Share by Applications in 2017
Figure Drugstore Picture
Figure Hospital Picture
Figure Others Picture
Figure United States Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure France Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure UK Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure China Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure India Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Opioid-Induced Constipation Revenue (Value) and Growth Rate (2013-2023)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Opioid-Induced Constipation Type and Applications
Table AstraZeneca Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Opioid-Induced Constipation Type and Applications
Table Takeda Pharmaceutical Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Pharmaceuticals International Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals International Opioid-Induced Constipation Type and Applications
Table Valeant Pharmaceuticals International Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Opioid-Induced Constipation Type and Applications
Table Abbott Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Opioid-Induced Constipation Type and Applications
Table Bayer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Opioid-Induced Constipation Type and Applications
Table Boehringer Ingelheim Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table C.B. Fleet Basic Information, Manufacturing Base and Competitors
Table C.B. Fleet Opioid-Induced Constipation Type and Applications
Table C.B. Fleet Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cosmo Pharmaceuticals Opioid-Induced Constipation Type and Applications
Table Cosmo Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Daewoong Basic Information, Manufacturing Base and Competitors
Table Daewoong Opioid-Induced Constipation Type and Applications
Table Daewoong Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Opioid-Induced Constipation Type and Applications
Table Daiichi Sankyo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Opioid-Induced Constipation Type and Applications
Table GlaxoSmithKline Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ironwood Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ironwood Pharmaceuticals Opioid-Induced Constipation Type and Applications
Table Ironwood Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Opioid-Induced Constipation Type and Applications
Table Johnson & Johnson Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Opioid-Induced Constipation Type and Applications
Table Merck Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mundipharma Basic Information, Manufacturing Base and Competitors
Table Mundipharma Opioid-Induced Constipation Type and Applications
Table Mundipharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table Nektar Therapeutics Opioid-Induced Constipation Type and Applications
Table Nektar Therapeutics Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Opioid-Induced Constipation Type and Applications
Table Pfizer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Progenics Pharmaceuticals Opioid-Induced Constipation Type and Applications
Table Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shionogi Basic Information, Manufacturing Base and Competitors
Table Shionogi Opioid-Induced Constipation Type and Applications
Table Shionogi Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SLA Pharma Basic Information, Manufacturing Base and Competitors
Table SLA Pharma Opioid-Induced Constipation Type and Applications
Table SLA Pharma Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sucampo Basic Information, Manufacturing Base and Competitors
Table Sucampo Opioid-Induced Constipation Type and Applications
Table Sucampo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synergy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Synergy Pharmaceuticals Opioid-Induced Constipation Type and Applications
Table Synergy Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Theravance Basic Information, Manufacturing Base and Competitors
Table Theravance Opioid-Induced Constipation Type and Applications
Table Theravance Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Opioid-Induced Constipation Sales by Manufacturer (2016-2017)
Figure Global Opioid-Induced Constipation Sales Market Share by Manufacturer in 2016
Figure Global Opioid-Induced Constipation Sales Market Share by Manufacturer in 2017
Table Global Opioid-Induced Constipation Revenue by Manufacturer (2016-2017)
Figure Global Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2016
Figure Global Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2017
Figure Top 3 Opioid-Induced Constipation Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Opioid-Induced Constipation Manufacturer (Revenue) Market Share in 2017
Figure Global Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Global Opioid-Induced Constipation Revenue and Growth Rate (2013-2018)
Table Global Opioid-Induced Constipation Sales by Regions (2013-2018)
Table Global Opioid-Induced Constipation Sales Market Share by Regions (2013-2018)
Table Global Opioid-Induced Constipation Revenue by Regions (2013-2018)
Figure Global Opioid-Induced Constipation Revenue Market Share by Regions in 2013
Figure Global Opioid-Induced Constipation Revenue Market Share by Regions in 2017
Figure North America Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Europe Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure South America Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure North America Opioid-Induced Constipation Revenue and Growth Rate (2013-2018)
Table North America Opioid-Induced Constipation Sales by Countries (2013-2018)
Table North America Opioid-Induced Constipation Sales Market Share by Countries (2013-2018)
Figure North America Opioid-Induced Constipation Sales Market Share by Countries in 2013
Figure North America Opioid-Induced Constipation Sales Market Share by Countries in 2017
Table North America Opioid-Induced Constipation Revenue by Countries (2013-2018)
Table North America Opioid-Induced Constipation Revenue Market Share by Countries (2013-2018)
Figure North America Opioid-Induced Constipation Revenue Market Share by Countries in 2013
Figure North America Opioid-Induced Constipation Revenue Market Share by Countries in 2017
Figure United States Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Canada Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Mexico Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Europe Opioid-Induced Constipation Revenue and Growth Rate (2013-2018)
Table Europe Opioid-Induced Constipation Sales by Countries (2013-2018)
Table Europe Opioid-Induced Constipation Sales Market Share by Countries (2013-2018)
Table Europe Opioid-Induced Constipation Revenue by Countries (2013-2018)
Figure Europe Opioid-Induced Constipation Revenue Market Share by Countries in 2016
Figure Europe Opioid-Induced Constipation Revenue Market Share by Countries in 2017
Figure Germany Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure UK Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure France Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Russia Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Italy Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Opioid-Induced Constipation Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Opioid-Induced Constipation Sales by Countries (2013-2018)
Table Asia-Pacific Opioid-Induced Constipation Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Opioid-Induced Constipation Sales Market Share by Countries 2017
Table Asia-Pacific Opioid-Induced Constipation Revenue by Countries (2013-2018)
Figure Asia-Pacific Opioid-Induced Constipation Revenue Market Share by Countries 2017
Figure China Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Japan Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Korea Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure India Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Southeast Asia Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure South America Opioid-Induced Constipation Revenue and Growth Rate (2013-2018)
Table South America Opioid-Induced Constipation Sales by Countries (2013-2018)
Table South America Opioid-Induced Constipation Sales Market Share by Countries (2013-2018)
Figure South America Opioid-Induced Constipation Sales Market Share by Countries in 2017
Table South America Opioid-Induced Constipation Revenue by Countries (2013-2018)
Table South America Opioid-Induced Constipation Revenue Market Share by Countries (2013-2018)
Figure South America Opioid-Induced Constipation Revenue Market Share by Countries in 2017
Figure Brazil Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Argentina Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Colombia Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Opioid-Induced Constipation Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Opioid-Induced Constipation Sales by Countries (2013-2018)
Table Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries in 2017
Table Middle East and Africa Opioid-Induced Constipation Revenue by Countries (2013-2018)
Table Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries in 2013
Figure Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries in 2017
Figure Saudi Arabia Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure UAE Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Egypt Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure Nigeria Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Figure South Africa Opioid-Induced Constipation Sales and Growth Rate (2013-2018)
Table Global Opioid-Induced Constipation Sales by Type (2013-2018)
Table Global Opioid-Induced Constipation Sales Share by Type (2013-2018)
Table Global Opioid-Induced Constipation Revenue by Type (2013-2018)
Table Global Opioid-Induced Constipation Revenue Share by Type (2013-2018)
Figure Global Solid Sales Growth (2013-2018)
Figure Global Solid Price (2013-2018)
Figure Global Liquid Sales Growth (2013-2018)
Figure Global Liquid Price (2013-2018)
Table Global Opioid-Induced Constipation Sales by Application (2013-2018)
Table Global Opioid-Induced Constipation Sales Share by Application (2013-2018)
Figure Global Hospital Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Opioid-Induced Constipation Sales, Revenue and Growth Rate (2018-2023)
Table Global Opioid-Induced Constipation Sales Forecast by Regions (2018-2023)
Table Global Opioid-Induced Constipation Market Share Forecast by Regions (2018-2023)
Figure North America Sales Opioid-Induced Constipation Market Forecast (2018-2023)
Figure Europe Sales Opioid-Induced Constipation Market Forecast (2018-2023)
Figure Asia-Pacific Sales Opioid-Induced Constipation Market Forecast (2018-2023)
Figure South America Sales Opioid-Induced Constipation Market Forecast (2018-2023)
Figure Middle East and Africa Sales Opioid-Induced Constipation Market Forecast (2018-2023)
Table Global Opioid-Induced Constipation Sales Forecast by Type (2018-2023)
Table Global Opioid-Induced Constipation Market Share Forecast by Type (2018-2023)
Table Global Opioid-Induced Constipation Sales Forecast by Application (2018-2023)
Table Global Opioid-Induced Constipation Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to choose PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....

About Report

Planet Market Reports added Latest and detailed market study report that focuses on “Global Opioid-Induced Constipation Market" Which offers essential information based on fresh ideas into Global Opioid-Induced Constipation Market industry along with unique market analysis which covers current top Manufactures in Global Opioid-Induced Constipation Market, growth, Consumption Demand, challenges, Historical data, subjects wise Survey of each chapters, Regional Insights, and Advancing industry trends, which will help our clients to aim Global Opioid-Induced Constipation Market. In addition, the report helps the customers to get a brief idea about Future demand and specifications of products which ensures the driving long-term income and productivity of global market.